Search research articles
Contact Us
Filters
Showing results (71-80 of 158) with videos related to
Page
of 16
Sort By:
Cancer Letters
|
September 4, 2025
Subtype-specific HER3 enrichment in basal-like breast cancer is regulated via the GATA2/GATA3-FOXA1 axis
Congcong Tan, Hui Lyu, Sanbao Ruan, et al.
Toxins
|
August 27, 2025
Mechanistic Exploration of Aristolochic Acid I-Induced Hepatocellular Carcinoma: Insights from Network Toxicology, Machine Learning, Molecular Docking, and Molecular Dynamics Simulation
Tiantaixi Tu, Tongtong Zheng, Hangqi Lin, et al.
The Journal of Craniofacial Surgery
|
March 12, 2021
Endoscopic Endonasal Transsphenoidal Approach for Third Ventriculostomy in the Management of Obstructive Hydrocephalus
Bolin Liu, Tao Zheng, Wenhai Lv, et al.
Oncology Reports
|
July 12, 2011
Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells
Hong Lin, Wei Xiong, Xiang Zhang, et al.
Cell Cycle (Georgetown, Tex.)
|
February 27, 2016
Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer
Reema Wahdan-Alaswad, J Chuck Harrell, Zeying Fan, et al.
International Journal of Biological Macromolecules
|
April 28, 2024
Fish oil-loaded multicore submillimeter-sized capsules prepared with monoaxial electrospraying, chitosan-tripolyphosphate ionotropic gelation, and Tween blending
Bolin Liu, Yulu Zheng, Jiawei Peng, et al.
Genes & Diseases
|
November 11, 2025
Synergistic anti-tumor activity of ciclopirox olamine and metformin in triple-negative breast cancer
Yakun Wu, Hui Lyu, Congcong Tan, et al.
NPJ Precision Oncology
|
August 3, 2023
HER3 targeting augments the efficacy of panobinostat in claudin-low triple-negative breast cancer cells
Hui Lyu, Defu Hou, Hao Liu, et al.
Oncotarget
|
December 2, 2015
The erbB3- and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cells
Hui Lyu, Xiao He Yang, Susan M Edgerton, et al.
BMC Cancer
|
June 18, 2011
Therapeutic potential of cladribine in combination with STAT3 inhibitor against multiple myeloma
Jian Ma, Shuiliang Wang, Ming Zhao, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 158) with videos related to
Sort By:
Page
of 16
Cancer Letters
|
September 4, 2025
Subtype-specific HER3 enrichment in basal-like breast cancer is regulated via the GATA2/GATA3-FOXA1 axis
Congcong Tan, Hui Lyu, Sanbao Ruan, et al.
Toxins
|
August 27, 2025
Mechanistic Exploration of Aristolochic Acid I-Induced Hepatocellular Carcinoma: Insights from Network Toxicology, Machine Learning, Molecular Docking, and Molecular Dynamics Simulation
Tiantaixi Tu, Tongtong Zheng, Hangqi Lin, et al.
The Journal of Craniofacial Surgery
|
March 12, 2021
Endoscopic Endonasal Transsphenoidal Approach for Third Ventriculostomy in the Management of Obstructive Hydrocephalus
Bolin Liu, Tao Zheng, Wenhai Lv, et al.
Oncology Reports
|
July 12, 2011
Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells
Hong Lin, Wei Xiong, Xiang Zhang, et al.
Cell Cycle (Georgetown, Tex.)
|
February 27, 2016
Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer
Reema Wahdan-Alaswad, J Chuck Harrell, Zeying Fan, et al.
International Journal of Biological Macromolecules
|
April 28, 2024
Fish oil-loaded multicore submillimeter-sized capsules prepared with monoaxial electrospraying, chitosan-tripolyphosphate ionotropic gelation, and Tween blending
Bolin Liu, Yulu Zheng, Jiawei Peng, et al.
Genes & Diseases
|
November 11, 2025
Synergistic anti-tumor activity of ciclopirox olamine and metformin in triple-negative breast cancer
Yakun Wu, Hui Lyu, Congcong Tan, et al.
NPJ Precision Oncology
|
August 3, 2023
HER3 targeting augments the efficacy of panobinostat in claudin-low triple-negative breast cancer cells
Hui Lyu, Defu Hou, Hao Liu, et al.
Oncotarget
|
December 2, 2015
The erbB3- and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cells
Hui Lyu, Xiao He Yang, Susan M Edgerton, et al.
BMC Cancer
|
June 18, 2011
Therapeutic potential of cladribine in combination with STAT3 inhibitor against multiple myeloma
Jian Ma, Shuiliang Wang, Ming Zhao, et al.
Page
of 16